University of Minnesota. Driven to Discover.
Antibiotic prescribing guided by C-reactive protein testing resulted in a lower rate of those drugs for COPD exacerbations in Britain.
Ceftazidime-avibactam, meropenem-vaborbactam, and plazomicin were added as "reserve" antibiotics.
A protocol involving urinalysis, absolute neutrophil count, and procalcitonin levels showed 97.7% sensitivity and 60.0% specificity.
Bacterial reads for unexplained sepsis were 1,000 times higher than with a different assay.
The new study sheds light on prescribing missed in other studies, including for conditions without an in-patient visit.
Research on the device indicates it has the potential to provide quick, low-cost diagnostics.
Whole-genome sequencing could lead to faster, more accurate resistance testing.
Fully 41% of antibiotic prescriptions written for patients with ARIs were inappropriate.
The study found no signifiant difference in patients with lower respiratory tract infections.
The test can yield results in less than an hour, compared with 24 to 48 hours for conventional tests.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.